scholarly journals Modeling Suggests a Mechanism of Synergy Between Hepatitis C Virus Entry Inhibitors and Drugs of Other Classes

2015 ◽  
Vol 4 (8) ◽  
pp. 445-453 ◽  
Author(s):  
P Padmanabhan ◽  
NM Dixit
2017 ◽  
Vol 114 (23) ◽  
pp. E4527-E4529 ◽  
Author(s):  
Hirofumi Ohashi ◽  
Yoshiki Koizumi ◽  
Kento Fukano ◽  
Takaji Wakita ◽  
Alan S. Perelson ◽  
...  

2013 ◽  
Vol 23 (23) ◽  
pp. 6467-6473 ◽  
Author(s):  
Jong Yeon Hwang ◽  
Hee-Young Kim ◽  
Dong-Sik Park ◽  
Jihyun Choi ◽  
Sung Min Baek ◽  
...  

2009 ◽  
Vol 72 (12) ◽  
pp. 2158-2162 ◽  
Author(s):  
Hongjie Zhang ◽  
Katharina Rothwangl ◽  
Andrew D. Mesecar ◽  
Ali Sabahi ◽  
Lijun Rong ◽  
...  

2011 ◽  
Vol 21 (22) ◽  
pp. 6852-6855 ◽  
Author(s):  
Gopi Kumar Mittapalli ◽  
Andrew Jackson ◽  
Fang Zhao ◽  
Haekyung Lee ◽  
Stephine Chow ◽  
...  

2021 ◽  
Vol 36 (1) ◽  
pp. 462-468
Author(s):  
Hyung Chul Ryu ◽  
Marc Windisch ◽  
Jee Woong Lim ◽  
Inhee Choi ◽  
Eun Kyu Lee ◽  
...  

2020 ◽  
Vol 21 (6) ◽  
pp. 2091 ◽  
Author(s):  
Che Colpitts ◽  
Pei-Ling Tsai ◽  
Mirjam Zeisel

Hepatitis C virus (HCV) is a major cause of chronic hepatitis and liver disease worldwide. Its tissue and species tropism are largely defined by the viral entry process that is required for subsequent productive viral infection and establishment of chronic infection. This review provides an overview of the viral and host factors involved in HCV entry into hepatocytes, summarizes our understanding of the molecular mechanisms governing this process and highlights the therapeutic potential of host-targeting entry inhibitors.


Sign in / Sign up

Export Citation Format

Share Document